Breaking News

Pet Care for Sun Care?

By Christine Esposito, Associate Editor | January 14, 2014

Merck and Novartis in discussions to swap businesses, sources say.

Several sources are reporting that Novartis and Merck are in discussion to trade select operations. A deal could shift Novartis’ animal-health and human vaccines units to Merck and send Merck’s OTC healthcare unit—including Coppertone—to the Swiss based drug firm, which operates in the US from a headquarter in Greensboro, NC.
 
Merck’s OTC business includes Claritin allergy medicine, which analysts see as a perfect fit for Novartis, which sells products like Triaminic, a cold medicine, and Lamisil, an anti-fungal treatment, directly to consumers through pharmacies. 

Merck’s major products in HAPPI’s markets include the iconic Coppertone sun care line as well as Bain de Soleil sun care products. It also sells A+D Ointment, Lotrimin, Tinactin and Dr. Scholl’s products.

Merck was ranked No. 25 in HAPPI's 2013 Top 50 Report.

Related End-User Markets:

blog comments powered by Disqus
  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016

  • Burgeoning Beauty

    Burgeoning Beauty

    Melissa Meisel, Associate Editor||January 4, 2016
    A look at trailblazers for 2016 and beyond.

  • Testing for Sustainable Preservatives

    Adam P. Byrne, William Michael Hart-Cooper, Kaj Johnson, Larry H. Stanker, Dominic W. S. Wong, William J. Orts||January 4, 2016
    A rapid, inexpensive and qualitative protocol for determining microbial growth inhibition.